The risk of stroke from atrial fibrillation (AFib) is real, and can quickly change a patient's life. As you know, the scientific evidence confirms that oral anticoagulation is highly effective at reducing stroke risk. Yet, elderly patients are too often under-anticoagulted, owing in part to their lack of understanding about stroke risk and the value of anticoagulation. This tip sheet offers talking points to help health care professionals help their patients to better understand why anticoagulation is critical and how adherence will allow them to celebate more years without a stroke.
A survey of more than 500 adults with atrial fibrillation age 65 and over, explored first diagnosis, referrals, their treatment decision process, anticoagulant use, medication switching, bleeding complications, and more.
Atrial fibrillation (also called AFib or AF) is the most common type of irregular heartbeat, or arrhythmia. An estimated five million Americans are currently living with AFib. People with AFib have a higher risk of stroke, heart failure, dementia, other heart-related complications, and even death. Read this brochure to find out more about this condition.